[Nicotine replacement therapies during pregnancy: what do we know about the balance between benefits and risks?]

Autor:	C, Heilbronner, I, Berlin
Jazyk:	francouzština
Rok vydání:	2005
Předmět:	Nicotine Smoking Risk Assessment Pregnancy Complications Disease Models Animal Fetus Treatment Outcome Pregnancy Risk Factors Prenatal Exposure Delayed Effects Animals Humans Female Smoking Cessation Nicotinic Agonists
Zdroj:	Journal de gynecologie, obstetrique et biologie de la reproduction. 34(7 Pt 1)
ISSN:	0368-2315
Popis:	Maternal smoking during pregnancy induces obstetrical and fetal complications but also has an impact on newborns, infants, children and adults. Nicotine replacement therapies are authorized during pregnancy in France, the purpose being to reduce fetal exposure to toxic compounds in tobacco smoke. However, it is not proven that nicotine replacement therapy is harmless to the fetus and to date, no study has demonstrated any beneficial effect in terms of abstinence. It is suggested that benefit and risks of nicotine replacement therapies during pregnancy should be evaluated.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::c7d188fd0528a26dac87e3a63043f8b5 https://pubmed.ncbi.nlm.nih.gov/16270006 Zobrazit plný text záznamu Full Text from ScienceDirect